AVITA Medical (RCEL) Return on Assets Growth (1y) (2021 - 2025)

AVITA Medical (RCEL) Return on Assets Growth (1y) (2021 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 183.59 Bn 176.29 Bn 6.27 Bn
2 Stryker 129.07 Bn 126.19 Bn 3.81 Bn
3 Medtronic 108.58 Bn 99.36 Bn 6.41 Bn
4 Boston Scientific 68.64 Bn 67.19 Bn 3.61 Bn
5 Edwards Lifesciences 48.38 Bn 44.71 Bn 1.29 Bn
6 Dexcom 28.35 Bn 27.23 Bn 750.30 Mn
7 GE HealthCare Technologies 28.13 Bn 25.84 Bn 1.98 Bn
8 Smith & Nephew 26.90 Bn 26.33 Bn -
9 Koninklijke Philips 24.27 Bn 21.15 Bn 2.07 Bn
10 AVITA Medical 132.90 Mn 116.55 Mn 14.31 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 0.00
Sep 30, 2025 0.00
Jun 30, 2025 0.00
Mar 31, 2025 0.00
Dec 31, 2024 0.00
Sep 30, 2024 -1.00
Jun 30, 2024 0.00
Mar 31, 2024 0.00
Dec 31, 2023 0.00
Sep 30, 2023 0.00
Jun 30, 2023 0.00
Mar 31, 2023 0.00
Dec 31, 2022 0.00
Sep 30, 2022 0.00
Jun 30, 2022 0.00
Mar 31, 2022 0.00
Dec 31, 2021 0.00
Sep 30, 2021 0.00